| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |